Search research articles
Contact Us
Filters
Showing results (91-100 of 119) with videos related to
Page
of 12
Sort By:
The Japanese Journal of Antibiotics
|
August 1, 1989
[Treatment with sulbactam/cefoperazone of severe infections in patients with hematological disorders]
R Ohno, T Hotta, M Ogura, et al.
Leukemia
|
November 1, 1991
Cytogenetic and clonal culture evaluation after response to low dose Ara-C in myelodysplastic syndromes
T Hotta, S Goto, K Tsushita, et al.
The European Respiratory Journal
|
April 1, 1988
Diagnostic value of cancer antigen 15-3 (CA15-3) detected by monoclonal antibodies (115D8 and DF3) in exudative pleural effusions
K Shimokata, Y Totani, K Nakanishi, et al.
Biochemistry
|
September 19, 2001
Structural requirements of sphingosine molecules for inhibition of DNA primase: biochemical and computational analyses
Y Ito, K Tamiya-Koizumi, Y Koide, et al.
Journal of Neurochemistry
|
September 2, 2005
Transcription factor specificity protein 1 (Sp1) is the main regulator of nerve growth factor-induced sphingosine kinase 1 gene expression of the rat pheochromocytoma cell line, PC12
S Sobue, K Hagiwara, Y Banno, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
July 1, 1995
Herbimycin A inhibits phorbol ester-induced morphologic changes, adhesion, and megakaryocytic differentiation of the leukemia cell line, MEG-01
T Murate, S Saga, M Hamaguchi, et al.
Experimental Hematology
|
January 1, 1993
Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity
T Murate, K Yamashita, H Ohashi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 8, 1998
Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma. The IDEC-C2B8 Study Group
K Tobinai, Y Kobayashi, M Narabayashi, et al.
International Journal of Hematology
|
June 19, 1998
A high dose chemoradiotherapy and peripheral blood stem cell support combined with the CD34(+)-selection method in cyclin D1(+)-mantle cell lymphoma
K Uehira, Y Kagami, M Ogura, et al.
Leukemia
|
April 14, 2000
Methylation status of the p15INK4B gene in hematopoietic progenitors and peripheral blood cells in myelodysplastic syndromes
E Aoki, T Uchida, H Ohashi, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 119) with videos related to
Sort By:
Page
of 12
The Japanese Journal of Antibiotics
|
August 1, 1989
[Treatment with sulbactam/cefoperazone of severe infections in patients with hematological disorders]
R Ohno, T Hotta, M Ogura, et al.
Leukemia
|
November 1, 1991
Cytogenetic and clonal culture evaluation after response to low dose Ara-C in myelodysplastic syndromes
T Hotta, S Goto, K Tsushita, et al.
The European Respiratory Journal
|
April 1, 1988
Diagnostic value of cancer antigen 15-3 (CA15-3) detected by monoclonal antibodies (115D8 and DF3) in exudative pleural effusions
K Shimokata, Y Totani, K Nakanishi, et al.
Biochemistry
|
September 19, 2001
Structural requirements of sphingosine molecules for inhibition of DNA primase: biochemical and computational analyses
Y Ito, K Tamiya-Koizumi, Y Koide, et al.
Journal of Neurochemistry
|
September 2, 2005
Transcription factor specificity protein 1 (Sp1) is the main regulator of nerve growth factor-induced sphingosine kinase 1 gene expression of the rat pheochromocytoma cell line, PC12
S Sobue, K Hagiwara, Y Banno, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
July 1, 1995
Herbimycin A inhibits phorbol ester-induced morphologic changes, adhesion, and megakaryocytic differentiation of the leukemia cell line, MEG-01
T Murate, S Saga, M Hamaguchi, et al.
Experimental Hematology
|
January 1, 1993
Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity
T Murate, K Yamashita, H Ohashi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 8, 1998
Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma. The IDEC-C2B8 Study Group
K Tobinai, Y Kobayashi, M Narabayashi, et al.
International Journal of Hematology
|
June 19, 1998
A high dose chemoradiotherapy and peripheral blood stem cell support combined with the CD34(+)-selection method in cyclin D1(+)-mantle cell lymphoma
K Uehira, Y Kagami, M Ogura, et al.
Leukemia
|
April 14, 2000
Methylation status of the p15INK4B gene in hematopoietic progenitors and peripheral blood cells in myelodysplastic syndromes
E Aoki, T Uchida, H Ohashi, et al.
Page
of 12